Thermo Fisher Scientific Inc. (LON:0R0H)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 159.52B |
| Revenue (ttm) | 32.61B |
| Net Income (ttm) | 4.90B |
| Shares Out | n/a |
| EPS (ttm) | 12.91 |
| PE Ratio | 32.56 |
| Forward PE | 23.60 |
| Dividend | 1.29 (0.23%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 2,089 |
| Average Volume | 4,415 |
| Open | 562.39 |
| Previous Close | 558.37 |
| Day's Range | 558.02 - 568.42 |
| 52-Week Range | 385.88 - 609.45 |
| Beta | 0.90 |
| RSI | 48.32 |
| Earnings Date | Jan 29, 2026 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial numbers in USD Financial StatementsNews
Top Stock Reports for Walmart, Wells Fargo & Thermo Fisher Scientific
Walmart's omnichannel execution, strong comps and expanding higher-margin businesses are driving outperformance despite cost pressures and tariff risks.
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer's Disease Registry to Advance Real-World Evidence in Neurodegenerative Care.
TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio
Thermo Fisher expands its Gibco Bacto CD portfolio with new formulations aimed at boosting E. coli-based plasmid DNA and protein production efficiency.
OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
LOS ANGELES--(BUSINESS WIRE)--OlivePoint acquires a Class A Raleigh office 100% leased to PPD/Thermo Fisher, highlighting its strategy to target mispriced, credit-backed assets.
Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (...
Looking At Thermo Fisher Scientific's Recent Unusual Options Activity
Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific (NYSE: TMO) revealed 9 unusual trades. Delving into the...
Ex-Dividend Reminder: DT Midstream, HCA Healthcare and Thermo Fisher Scientific
Looking at the universe of stocks we cover at Dividend Channel, on 12/15/25, DT Midstream Inc (Symbol: DTM), HCA Healthcare Inc (Symbol: HCA), and Thermo Fisher Scientific Inc (Symbol: TMO) will all t...
Citi Upgrades Thermo Fisher Scientific (TMO) to Buy, Raises Price Target
Citi Upgrades Thermo Fisher Scientific (TMO) to Buy, Raises Price Target
Thermo Fisher upgraded at Citi on boost in pharma spending
Citigroup Upgrades Thermo Fisher Scientific (TMO), Raises Price Target | TMO Stock News
Citigroup Upgrades Thermo Fisher Scientific (TMO), Raises Price Target | TMO Stock News
If You Invested $100 In Thermo Fisher Scientific Stock 10 Years Ago, You Would Have This Much Today
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 10 years by 2.35% on an annualized basis producing an average annual return of 15.14%. Currently, Thermo Fisher Scientif...
Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs
Goldman Sachs names Agilent, Danaher, and Thermo Fisher Scientific as top life sciences stock picks. Read more here.
Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack
The Investment Committee debate the latest Calls of the Day.
Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack
The Investment Committee debate the latest Calls of the Day.
Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TMO) with 'Buy' Rating | TMO ...
Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TMO) with 'Buy' Rating | TMO Stock News
Keybanc Upgrades Thermo Fisher Scientific (TMO) to 'Overweight' with Price Target of $750 | TMO ...
Keybanc Upgrades Thermo Fisher Scientific (TMO) to 'Overweight' with Price Target of $750 | TMO Stock News
Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening
UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE: TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test. TMO is lagging b...
Thermo Fisher Scientific (TMO) Expands Bioprocessing Presence in Asia
Thermo Fisher Scientific (TMO) Expands Bioprocessing Presence in Asia
Thermo Fisher Scientific deepens investment in Asia’s biopharma ecosystem
Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitm...
Top 15 High-Growth Dividend Stocks For December 2025
The Top 15 High-Growth Dividend Stocks for December 2025 offer a 1.58% yield and 20.97% five-year dividend growth, appearing 33% undervalued. The watchlist's goal is a 12% long-term CAGR, with Novembe...
Thermo Fisher Scientific (TMO) Announces â¬2.1 Billion Senior Notes Offering
Thermo Fisher Scientific (TMO) Announces â¬2.1 Billion Senior Notes Offering
HSBC Upgrades Thermo Fisher Scientific (TMO) to 'Buy' | TMO Stock News
HSBC Upgrades Thermo Fisher Scientific (TMO) to 'Buy' | TMO Stock News
Is the Market Bullish or Bearish on Thermo Fisher Scientific Inc?
Thermo Fisher Scientific Inc's (NYSE: TMO) short interest as a percent of float has risen 12.5% since its last report. According to exchange reported data, there are now 4.41 million shares sold shor...
Price Over Earnings Overview: Thermo Fisher Scientific
In the current market session, Thermo Fisher Scientific Inc. (NYSE: TMO) stock price is at $592.02, after a 0.96% drop. However, over the past month, the company's stock went up by 5.32% , and in the...